of the urea backbone. This study culminated in the selection of N'-(2,4-dimethylphenyl)-N-benzyl-N-n-butylurea (115) for more extensive biological evaluation. ACAT inhibitors are seen as potentially beneficial agents against hypercholesterolemia and atherosclerosis.
一系列N,N-二烷基-N'-芳基
脲是ACAT酶的
抑制剂的发现导致了结构活性研究,涉及系统修饰
尿素主链的三个位点。这项研究最终选择了N'-(2,4-二甲基苯基)-N-苄基-Nn-丁基
脲(115),以进行更广泛的
生物学评估。ACAT
抑制剂被视为对抗高
胆固醇血症和动脉粥样硬化的潜在有益药物。